Botulinum toxin type F

DB16986Experimental

Botulinum toxin type F: Overview.

Resolves to

Compound
UNIIU1R2P71O7G

Which companies are running trials of Botulinum toxin type F, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In